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Introduction
The bovine leukemia virus (BLV), which is structurally and functionally related to the human T-lymphotropic virus types (HTLV)-I and II, is the etiological agent of enzootic bovine leukosis (EBL) [1] . Besides the difference in host range, a notable difference between the two viruses is that, infection by BLV is associated with malignancy of CD5 + B-cells, whereas HTLV affects CD4 + T-cells, the majority of which harbor the provirus. Infection by BLV can remain clinically inapparent with the host in an aleukemic state (AL), or it can emerge as persistent lymphocystosis (PL) with non-malignant polyclonal expansion of CD5 + B-cell, the majority of which harbor BLV provirus and, more rarely, as malignant B-cell lymphosarcoma in various lymph nodes after a long latent period [2] . Resistance or susceptibility to BLV-induced disease is reportedly determined by several host immune responses [3] . However, the way in which BLV induces the different disease stages during the progression of EBL is still unknown.
Tumor necrosis factor (TNF)-α is of central importance in viral dynamics because, along with other cellular immunity associated cytokines, it is thought to be a protective factor in the progression of various viral infections [4, 5] . In our previous reports, we have shown that the expression of TNF-α is closely associated with disease progression in sheep experimentally infected with BLV [6, 7] . Interestingly, we observed that the expression of the TNF-α mRNA was significantly up-regulated in BLV infected sheep, resulting in elimination of BLV-infected cells. In contrast, sheep with down-regulated TNF-α mRNA expression showed no elimination of BLV-infected lymphocytes [6] .
Recently, Muller and co-workers [8] reported that the lack of TNF-α expression resulted in enhanced persistence of BLV-infection in TNF-α -/-mice. These findings suggest an important role played by TNF-α in the elimination of BLV during the early phase of the infection. However, it still remains unclear whether the level of TNF-α expression directly co-relates to the rate of elimination of BLV-infected cells in infected individuals. One hypothesis is that differences in genetic background could elicit different immune responses resulting in either resistance or susceptibility to disease.
Nucleotide sequence polymorphisms in genes of some cytokines have been shown to determine the specificity of an individual's immune response and to play roles in conferring resistance or susceptibility to human retroviral infections. Indeed, the association between the provirus load, the susceptibility to disease progression after infection with BLV-related HTLV and the TNF gene polymorphism have been reported [9] [10] [11] [12] . However, it remains to be determined whether bovine cytokine genetic polymorphisms, including TNF-α, could influence resistance or susceptibility to infectious diseases in the same way like human retroviral infections do. In addition, there is very little information available about cytokine genetic polymorphism and disease progression in domestic animals including cattle. Therefore, it is necessary to investigate the association between the genetic background of domestic animals and their resistance to some infectious diseases. Here, to evaluate the possible role played by TNF-α gene polymorphisms in the propagation of BLV and the modulation of the progression of the ensuing disease, we analyzed TNF-α genes of BLV-infected cattle and show that TNF-α -824G is associated with increased progression of BLV-induced lymphoma.
Materials and Methods

Characteristics of subjects
The characteristics of study subjects are summarized in Table 1 . A sample group comprising 291 individuals (Japanese black, Holstein-Friesian and First filial of Japanese black/Holstein-Friesian) from thirty-two different dairy farms located in four different areas (Hokkaido, Iwate, Gifu and Niigata) were investigated. It was presumed that the likelihood of the animals being related was remote. Genomic DNA was extracted from whole blood using the Wizard TM Genomic DNA Purification kit (Promega, Madison, WI) as previously described [13] . Purified genomic DNA concentration was measured by optical density (OD) at 260 nm and stored at 4°C until use. BLV infection was tested by the agar gel immuno-diffusion assay using the BLV env glycoprotein gp51 as antigen, and was further confirmed by real-time PCR, using primer pair BLV-LTR256 (5'-GAG CTC TCT TGC TCC CGA GAC-3') and BLV-LTR453 (5'-GAA ACA AAC GCG GGT GCA AGC CAG-3'), to amplify the BLV long terminal region (LTR) using a LightCycler TM (Roche Diagnostics, Mannheim, Germany) as described previously [14] . BLV-infected cells were quantified based on viral genome amplification by real-time PCR as described previously [14] .
Twenty-five animals with lymphoma were diagnosed clinically, and confirmed by microscopic and histological examinations [15] . Other BLV-positive animals were classified as AL or PL based on the amount of leukocytes and the percentage of lymphocytes in their whole blood [13] . Animals were regarded as PL if at least two consecutive leukocyte counts including lymphoid cells were more than 10,000/µl.
Genotyping of TNF-a gene
TNF-α -824A/G, -793C/T and -627C/G were genotyped by direct sequence analysis as previously described with minor modifications [16] . DNA fragments of 639bp
(from -1044 to -406) upstream of the non-coding region of TNF-α gene [17] , were PCR amplified using primer pair TNFA sense (5-CTG GAG AAG TGG GGG TCA-3) and TNFA anti-sense (5-TTA GAA ATG GGA GGG GCT TTA T-3) as described previously [16] . The PCR product was purified with the Gene-clean-III Kit The C-T substitution at position in exon 4 of the TNF-α gene was examined by the PCR-restriction fragment length polymorphism (RFLP) method [18] , using primer pair:
forward (5'-GGG TGA CTT GCT CTA ACA CTC ATC-3') and reverse (5'-AGG CCT CAC TTC CCT ACA TCC CTA-3'). The PCR products (1233 bp fragments) were subjected to RsaI (Takara, ostu, Japan) restriction enzyme digestion at 37°C for 16 h fractionated on 1% agarose gel. The digestion would result in either an intact fragment (the C allele; RsaI*C) or one cut into two fragments of 928 and 305 bp (the T allele;
RsaI*T).
To confirm the identity of the nucleotide, the products were sequenced as described above.
The data were analyzed following the method described Nishimura et al [10] . The statistical significance of the data was determined by the Chi-square method using the Statcel2 software (OMS, Saitama, Japan). To determine the significance of the deviation, Fisher's exact probability test was used when the number of variables expected per cell was less than five. The corrected p values (pc) were obtained by multiplying the uncorrected P values (pu) with the number of comparisons; p < 0.05 was taken as the level of significance.
Construction of luciferase fusion plasmids
The two naturally occurring allelic forms of the TNF-α promoter (TNF-α -824A and TNF-α -824G) were cloned into the luciferase reporter gene construct ( Fig. 2A) . The TNF-α promoter fragments with A or G at -824 were amplified from genomic DNA isolated from heterozygous cattle using PCR primers (TNFA sense and TNFA anti-sense) containing NheI (Takara) and XhoI (Takara) restriction sites, respectively.
The resulting NheI-XhoI fragments were cloned into the NheI and XhoI restriction sites 
Transfections and luciferase assays
Human embryonic kidney 293T cells, fetal lamb kidney (FLK) and BLV-infected (RIKEN), Wako, Japan) or the control plasmid (pME18Neo) as described previously [19] . Twenty-four hours after transfection, cells were harvested and their lysates assayed using Dual-Luciferase Reporter Assay System (Promega) as described by the manufacturer. The luciferase activities of triplicate cultures were determined using a Luminescencer-JNR AB2010 (ATTO bio-instrument, Tokyo, Japan). For each sample, the firefly luciferase activity (pGL3 vector) was normalized by reference to Renilla luciferase activity (pRL-TK). The extent of trans-activation (-fold) was calculated by dividing the trans-activation activity of each plasmid by that of the cell lysate transfected with the control plasmid. Data were analyzed by one-way analysis of variance followed by Student t-test. Differences between groups were considered significant if probability values of p<0.05 were obtained
Quantification of TNF-a mRNA
Total RNA was extracted from freshly isolated or cultivated PBMCs (peripheral blood mononuclear cells) by using the TRIZOL TM reagent according to the manufacturer's protocol (Invitrogen). All samples were treated with deoxyribonuclease I (amplification grade, Invitrogen) to eliminate DNA contamination.
cDNA was synthesized with the Transcriptor 1st Strand cDNA Synthesis kit (Roche Diagnostics) according to the manufacture's instructions. Real-time RT-PCR using SYBER Green I was performed using a LightCycler TM (Roche Diagnostics) as described previously [13] . The cDNA template was added to a total volume of 20 µl containing PCR buffer, oligonucleotide primers (at 0.2 µM each of TNF-α sense: 5'-TAA CAA GCC GGT AGC CCA CG-3' and TNF-α anti-sense: 5'-GCA AGG GCT CTT GAT GGC AGA-3') [20] , and 2 µl of LightCycler-Fast Start DNA Master SYBER Green I (Roche Diagnostics). The bovine β-actin gene in each sample was also amplified using primer pair β-actin sense (5'-CGC ACC ACT GGC ATT GTC AT-3') and β-actin anti-sense (5'-TCC AAG GCG ACG TAG CAG AG-3') to check for loading of template cDNAs. The relative mRNA values were worked out as ratios by dividing the concentration of the PCR product from the TNF-α cDNA by that from the β-actin cDNA. Data were analyzed by one-way analysis of variance followed by Student t-test. Differences between groups were considered significant if probability values of p<0.05 were obtained.
RESULTS
Association of -824A/G polymorphism of TNF-a promoter with BLV disease progression in cattle
There were no significant differences in the frequency of TNF-α alleles between BLV-positive and -negative controls ( Table 1 ). The frequencies of TNF-α alleles in BLV-infected cattle, AL, PL and lymphoma are shown in Table 2 . Regarding the frequencies of the -793C/T and the -627C/G alleles, BLV-infected but healthy cattle without lymphoma and cattle with lymphoma showed similar distribution. In contrast, Regarding the frequencies of the C/T genotype at the RsaI restriction site in exon 4, BLV-infected cattle without lymphoma and cattle with lymphoma also showed similar distribution, although statistically significant differences were found in the distribution of the genotype between lymphoma-positive and AL cattle. In addition, the RsaI C/T polymorphism did not result into amino acid substitution. Thus, this appears not to be associated with disease progression.
Polymorphism in TNF-a promoter region and the provirus load
To further evaluate the association of the -824A/G polymorphism of TNF-α promoter with the viral propagation rate in BLV-infected individuals, the provirus loads were determined in 107 BLV-infected cattle without any clinical evidence of lymphoma by real-time PCR system. There were no significant differences in the provirus load between the -824A/A homozygote and the -824A/G heterozygote cattle. In contrast, the provirus load was significantly increased in cattle with -824G/G homozygote allele However, in contrast to the previous experimental study in sheep [6] , TNF-α mRNA levels were found to be low or undetectable in cattle naturally infected with BLV and bearing the -824A/G heterozygote, -824A/A homozygote or -824G/G homozygote alleles (data not shown).
Transcriptional promoter activity of the TNF-a gene
We performed the luciferase assay to assess whether TNF-a -824A/G influences the transcriptional promoter activity of the TNF-α gene (Fig. 2B, C and D) . In 293T cells, the -824A promoter showed significantly higher luciferase activity than the -824G promoter in the cells (4.70±0.46 vs 3.09±0.43; p < 0.02) (Fig 2B) . Similarly, the mean transcriptional promoter activities were significantly increased in -824A promoter compared to -824G promoter in FLK-cells (6.07±0.14 vs 2.34±0.08; p < 0.001, Fig 2C) and FLK-BLV cells (9.28±0.41 vs 2.25±0.65; P < 0.001, Fig. 2D ). The BLV-Tax proteins were identified originally as factors that activated transcription from the respective BLV-LTR. In addition to its role in the activation of the viral enhancer, the Tax proteins of HTLV-1 and BLV modulates the expression of a variety of cellular genes that are related to the regulation of cell growth, via interaction with distinct promoter/enhancer sequences. To check this possibility, we examined if the transcriptional promoter activity of the TNF-α gene could be influenced by BLV-Tax.
However, no detectable modification of the transactivation was observed between -824A promoter and -824G promoter in BLV-negative FLK cells expressing BLV-Tax, whereas the BLV-Tax strongly transactivated the plasmid pGL3-BLV-LTR/Luc which contains a viral promoter. We could not, however, confirm the up-regulation of transactivation in BLV-infected cells (FLK-BLV cells), although the transcriptional promoter activity was significantly higher in the -824A allele than in the -824G allele.
TNF-a expression in PBMCs derived from cattle with different promoter polymorphism
In order to investigate the differences in the expression levels of the TNF-α in cattle with different promoter polymorphism, we used real-time PCR to quantify the expression of TNF-α mRNAs in concanavalin A-stimulated PBMC isolated from normal cattle (Fig. 3) . A limited number of cattle were tested (2 Japanese black and 2
Holstein-Friesian), yet as expected, the degree of TNF-α mRNA expression was notably higher in cattle with the -824A/G heterozygote allele than in cattle with the -824G/G homozygote allele. Un-stimulated PBMCs did not show any differences in the TNF-α expression levels among cattle (data not shown). Thus, these results
suggest that TNF-a -824A/G allele could influence the expression level of TNF-α and subsequent elimination of BLV. However, the results need to be confirmed using a larger sample size of cattle carrying different alleles and including BLV-infected cattle.
DISCUSSION
TNF-α is involved in host defense and is a protective factor against the progression of various viral infections [4, 5] . In BLV-infected animals, a good correlation was observed between up-regulation of TNF-α and BLV clearance or resistance to disease progression but with notable individual variations [6] . We had hypothesized that the differences in expression levels of TNF-α brought about by the different genetic backgrounds of individuals could be responsible for the differences in TNF-induced responses to BLV infection among different individuals. In the present study, to evaluate this possibility, we investigated the polymorphisms in the 5'-flanking region of the TNF-α gene during the different stages of BLV infection, and found that the frequency of the TNF-α -824G allele, which has been associated with high proviral loads, was higher in individuals with BLV-induced lymphoma than in healthy carriers or normal controls. We also observed higher luciferase activity and increased concanavalin-A stimulated TNF-α mRNA expression in TNF-α -824A allele than in the TNF-α -824G allele.
Although the role played by the TNF-α promoter region -824 A/G polymorphism in tumorigenesis of the BLV-induced lymphoma is still speculative, our findings underscore earlier reports associating polymorphisms in the TNF-α promoter/enhancer region and disease progression in human (Fig 4) . In the case of HTLV-I infection, the association of provirus load and TNF-α promoter polymorphism at position -1031 and
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-863 has been reported in HTLV-I associated uveitis (HU) patients [9] . Nishimura et al [10] found that the distribution of the -857T/C genotype was significantly different between HTLV-I-associated myelopathy (HAM) patients and sero-negative controls.
In addition, Tukasaki et al [11] found that the frequency of the TNF-α -857T allele,
reported to be associated with high transcriptional activity of the promoter/enhancer region of the TNF-α gene, was increased in individuals with T-cell leukemia/lymphoma (ATL) compared with healthy carriers. These observations point to the idea that TNF-α gene expression levels are associated with the polymorphisms in its promoter sequence. Indeed, Higuchi et al [22] reported that the transcriptional promoter activities of the -1031C, -863A and -857T TNF-α promoter alleles in response to concanavalin A stimulation of PBMCs (as revealed by luciferase assay), were higher than those of the dominant alleles in human. In these polymorphisms in the TNF-α promoter, a number of studies have indicated that the polymorphisms in the promoter region change the binding of various nuclear factors that up-or down-regulate transcription. Interestingly, Heel et al [23] demonstrated that the transcription factor OCT-1 binds the TNF-857T of the TNFP-D allele, but not the -857C of the TNFP-A, B
and C alleles and interacts in vitro and in vivo with the proinflammatory NF-κB transcription factor p65 subunit at the adjacent binding site, -863C/A. Therefore, it seems likely that these polymorphisms in the TNF-α promoter could influence to susceptibility to several infectious diseases in human. Although, the roles of the polymorphisms of the bovine TNF-α gene have not been reported, we postulated that the -824A/G polymorphism might be associated with expression of TNF-α for BLV-elimination. To check this possibility, the RNA transcripts of TNF-α gene in fresh PBMCs were analyzed among BLV-infected cattle with different TNF-α genotypes. However, no detectable expression of TNF-α was observed in fresh PBMC (data not shown). In addition, although the mean TNF-α protein levels were higher in BLV-infected cattle than the control cattle as described previously [24] , the difference between the two groups was not statistically significant. There were also no significant differences among cattle with different TNF-α genotypes (data not shown).
The importance of TNF-α for the antiviral response and for tumor promotion is well established. In particular, Mullar and co-workers [8] , using a TNF-α -/-mice model, have shown that the ability of the host to mount a TNF-α response is crucial in the host's immune defense system during the first phase of BLV infection. These data, although not showing statistically significant difference between the test group and the controls, might suggest that TNF-α has a defense function in the early phase of BLV infection. Further elucidation of the differences in TNF-α production in relation to the TNF-α -824A/G polymorphisms is inevitable.
On the other hand, we had previously reported contrasting roles played by TNF-α in the pathogenesis of BLV-infection in the early phase of infection. In the late phase of the infection, B-cell derived TNF-α was shown to strongly induce the proliferative response of B-cells upon binding to the specific receptors, TNF-RI and TNF-RII.
Further, the susceptibility to viral infection and development of the BLV-infection was shown to be determined by TNF-induced responses and linked to the binding of TNF-α to its receptors [7, 13, 24] . In HTLV-I infection, aberrant production of several cytokines and their receptors was thought to be a result of the transactivating ability of the Tax protein of HTLV-I. Although the role played by the BLV Tax is unknown, it has, nevertheless, been shown to enhance nuclear protooncogene such as c-fos [19] . Both genetic and immunological factors contribute to susceptibility to BLV-induced disease progressions [3, 26] . In genetic analysis of BLV-infection, previous studies revealed the polymorphism in bovine leukocyte antigen (BoLA)-DRβ chain associated with resistance to expansion of BLV [27] and PL [28] . Furthermore, it appeared that ovine leukocyte antigen (Ovar)-DRB1 alleles encoding the RK motif at positions 70-71 of the Ovar-DRβ chain might protect against tumor development after experimental infection of sheep with BLV [29] , and sheep with alleles encoding the RK motif could induce cellular immunity [30] . In this report, we showed that polymorphisms in the TNF-α promoter, -824G, which indicated low transcriptional activity, is associated with the BLV-induced lymphoma and elevation of provirus load in BLV-infected individuals.
To our knowledge, this is one of the first reports showing a cytokine genetic related to retroviral infections were cited from the reports by Seki et al [9] , Tsukasaki et al [11] and Nishimura et al [10] . Data on different TNF-α expression levels in relation to TNF-α promoter polymorphism were taken from the report by Higuchi et al [22] . 
